Roche is expanding the use of digital tools and artificial intelligence across its global laboratory operations, combining automated supply chain management with AI-driven research workflows designed to accelerate drug discovery.
The company has implemented a cloud-based inventory management platform across more than 1,000 laboratories in over 50 countries to improve visibility and control over laboratory consumables and reagents. The system connects laboratory inventory data with enterprise resource planning systems to support automated tracking, restocking, and supply chain oversight.
For laboratory managers overseeing complex operations, the shift toward digital laboratory supply chain management reflects a broader effort across the life sciences sector to reduce manual inventory processes and improve procurement efficiency.
Roche expands laboratory supply chain management
The inventory platform, developed with supply chain software provider Tecsys, supports lab inventory automation by tracking reagent usage and consumable supplies in real time. The system integrates with Roche’s SAP backend, providing centralized visibility into laboratory supply levels and procurement activity.
According to Tecsys CEO Peter Brereton, the technology is intended to modernize laboratory logistics by improving inventory oversight and reducing operational bottlenecks.
The platform is designed to minimize manual inventory errors, prevent stock shortages, and support regulatory compliance in laboratory environments where reagent availability is critical to maintaining testing workflows.
For laboratories operating across multiple locations, automated inventory tracking systems can also help standardize procurement processes and improve forecasting for high-demand consumables.
Strengthening laboratory supply chains in global markets
In addition to implementing digital supply chain tools, Roche has also taken steps to simplify distribution networks in certain regions.
In Nigeria, the company transitioned to a direct buy-and-sell model designed to reduce the number of intermediaries involved in the distribution of medicines and diagnostic products. The shift was intended to improve cold chain oversight and reduce price markups associated with multi-tier distribution structures.
According to Roche Products Nigeria country manager Ladi Hameed, the previous distribution model involved multiple intermediaries, each adding markups and introducing potential risks to product quality if cold-chain conditions were not consistently maintained.
Direct distribution approaches may help healthcare organizations maintain tighter control over supply chain conditions while improving access to essential diagnostic products and treatments.
AI drug discovery and the “lab in a loop” model
Alongside supply chain modernization efforts, Roche is expanding its use of artificial intelligence to support drug discovery workflows.
Through its Genentech research organization, the company is applying a “lab in a loop” model that integrates AI predictions with experimental laboratory data. In this approach, experimental and clinical data are used to train machine learning models that predict drug targets, therapeutic molecules, and antibody designs.
“The ‘lab in a loop’ is a mechanism by which you bring generative AI to drug discovery and development,” said Aviv Regev, head of Genentech Research and Early Development.
AI systems can rapidly screen potential molecular candidates and suggest new therapeutic strategies. Laboratory experiments then generate additional data that feed back into the models, improving prediction accuracy over time.
Implications for laboratory operations
The combination of digital supply chain tools and AI-driven research platforms illustrates how large life science organizations are integrating data systems across laboratory operations.
Advanced Lab Management Certificate
The Advanced Lab Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
Automated laboratory supply chain management systems may help organizations reduce administrative workload, improve inventory accuracy, and maintain consistent reagent availability for testing and research activities.
At the same time, AI-supported research workflows are reshaping experimental design by enabling laboratories to test computational predictions more rapidly and generate data that continuously refines machine learning models.
As laboratory networks become increasingly data-driven, platforms that integrate inventory systems, research data, and AI analytics may play a growing role in how life science organizations manage both operations and discovery.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
